Meta-analyses reveal the effectiveness of psychedelic therapy in treating patients with PTSD and depression, suggesting new approaches to mental health care.
Psychedelic medication, when used to facilitate a psychotherapy process, can provide a very different and powerful way to allow patients to access emotions, thoughts, beliefs and traumatic memories that may otherwise remain subconscious or hard to access. This treatment is currently available privately in Australia for patients with treatment-resistant PTSD and depression. Meta-analyses of clinical trial results to date have shown some substantial effect sizes. Such trials continue to clarify and expand indications, efficacy and safety, as not everyone is suited to, safe for or will respond to psychedelic treatment.
No takes yet. Share an insight, caveat, or question.
Anthony Helman (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: